An interventional study of Whey Protein Supplement and Carbohydrate Placebo Control in Body Weight Changes, Athletic Performance and Recovery, sponsored by University of Utah. Completed at 1 site in United States. Open to participants aged 13 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-27.
Sponsored by University of Utah · Not applicable, Interventional, and Other
The overall aim of this project is to compare protein supplementation on performance, recovery, and body composition changes in adolescent soccer players between the whey protein and the control group in response to the 10-12-week intervention.
Informed Consent, Parental Permission and Assent: These will be obtained over Zoom, prior to participation in any study procedures.
Randomization: Randomization will occur following baseline testing. Participants will be randomized via random number generator stratified by sex, into either the whey protein supplement group or the placebo (isocaloric) control group.
Baseline and Post-Intervention testing will occur over a single day for each participant.
Baseline:
All athletes will report to testing facilities for a single blood draw to measure inflammatory biomarkers and a body composition assessment (via BodPod) to measure fat mass and fat free mass. Participants will then be escorted to a track where they will run a 30-yard dash to assess their speed and a 1.5-mile run to assess their estimated maximal rate of oxygen consumption (VO2max). Participants will then be transferred back to the testing facility where they will undergo assessment of lower body muscle fatigue (via HumacNorm).
Questionnaires: Athletes will complete the Munich Chronotype Questionnaire and the Pittsburg Sleep Quality Index (PSQI). Participants will also complete 3-day, 24-hour dietary recalls (via ASA-24).
Sleep measures: Fitbit (Inspire 2) will be used measure sleep efficiency, duration, and staging. Fitabase will be utilized to receive Fitbit data. Participants will be instructed to wear their Fitbit for 1-week.
Intervention:
In-season soccer practices and competition will occur 6-days per week across a 10-12 week period, depending on how far teams advance in postseason play. During the 10-12-weeks, participants will consume their assigned supplement or placebo twice per day, every day, immediately after practice or competition (or midday on rest days), and \~1 hour before bedtime.
Sleep measures: Sleep measures will be evaluated as described above. Sleep measures will be collected at weeks 2, 4, 6, 8, and 10.
Questionnaires: Participants will complete 3-days of 24-hour dietary recalls (via ASA-24) at weeks 5 and 10. Pittsburg Sleep Quality Index (PSQI), a delayed-onset muscle soreness questionnaire and a GI symptom Questionnaire will be completed at weeks 2, 4, 6, 8 and 10.
Urine Samples: We will randomly assign participants to provide urine samples at weeks 4 and 7 as a sham measure of compliance to supplementation protocol.
Post-testing will be the same as pre-testing and will commence after the 10-12-week competitive season. All measures described above in baseline testing will be repeated.
231 studies on the registry are indexed under Body Weight Changes; 30 are open to participants now.
This study's enrollment of 31 is below the median of 80 across 179 interventional studies indexed under Body Weight Changes.
Browse Body Weight Changes studies →University of Utah is the lead sponsor of 994 studies on the registry; 175 are open to participants now.
Of its 114 completed or terminated interventional studies of FDA-regulated products, 69 (61%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Whey protein will come in powder form and will consist of 20g of protein, and 25.3g of product. We will use Optimum Nutrition Double Chocolate Whey Protein Isolate.
Dietary Supplement: Whey Protein Supplement
Carbohydrate control will come in powder form and will consist of 20g of carbohydrate and 21.6g of product. We will use Nesquik Chocolate Powder mix.
Dietary Supplement: Carbohydrate Placebo Control
Participants assigned to the intervention will consume the supplement mixed with 6-8oz of water every day, twice per day, after soccer practice or soccer games, and one hour before bedtime.
Also known as: Optimum Nutrition Gold Standard 100% Whey
Participants assigned to the placebo control will consume the supplement mixed with 6-8oz of water every day, twice per day, after soccer practice or soccer games, and one hour before bedtime.
Also known as: Nesquik Chocolate Powder
Estimated VO2max
Measured via 1.5-mile run time with participants running as quickly as they can.
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Changes in Muscular Fatigue Via Repetitions to Fatigue
Measured via leg extension machine (HumacNorm) using isometric muscle contraction in the quadriceps muscle. Repetitions to fatigue was defined as the total number of consecutive maximal isometric contractions completed until force output declines below a predetermined threshold (e.g., \<45% of peak torque).
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Changes in Speed
Measured using a 30 yard sprint
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Changes in Muscular Strength
This outcome is measured via maximum voluntary contraction from an isometric mid-thigh pull.
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Changes in Fat Free Mass
Measured via BodPod to assess the amount of fat-free mass each participant has (kg)
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Changes in Fat Mass
Measured via BodPod to assess the amount of fat mass each participant has (kg)
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Sleep Efficiency
Measured via Fitbit devices. Sleep efficiency is measured based on how long and individual is asleep over the time spent in bed during the night.
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Sleep Duration
Measured via Fitbit devices. Sleep duration is measured based on how long the individual is asleep.
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Changes in Adiponectin
Measured via blood sample to assess levels of fatty acid oxidation as well as inflammation
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Changes in BDNF
Measured via blood sample
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Changes in Follistatin
Measured via blood sample to assess muscle hypertrophy
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Changes in Sleep Quality
Measured via Pittsburgh Sleep Quality Index questionnaire. The questionnaire consists of a combination of Likerttype and open-ended questions. Each component is scored from 0 to 3, with higher scores indicating greater sleep disturbance or poorer sleep quality. Component scores are summed to yield a global PSQI score ranging from 0 to 21. A global PSQI score \>5 is commonly used to indicate poor sleep quality, whereas scores ≤5 indicate relatively good sleep quality. Each component is scored from 0 to 3, with higher scores indicating greater sleep disturbance or poorer sleep quality. Component scores are summed to yield a global PSQI score ranging from 0 to 21.
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Protein Intake
Measured via a 3-day food recall
Time frame: Measured at baseline and post-intervention (10-12-weeks)
Participants (13-18 years old) were recruited from Marsh Valley High School boys and girls' soccer teams in July of 2022.
| Milestone | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Started | 15 | 15 |
| Completed | 10 | 12 |
| Not completed | 5 | 3 |
Measured via 1.5-mile run time with participants running as quickly as they can.
| ml/kg/min | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 43.8 ± 2.41 | 42.0 ± 1.51 |
| Post-intervention | 47.9 ± 2.52 | 44.5 ± 1.64 |
Measured via leg extension machine (HumacNorm) using isometric muscle contraction in the quadriceps muscle. Repetitions to fatigue was defined as the total number of consecutive maximal isometric contractions completed until force output declines below a predetermined threshold (e.g., \<45% of peak torque).
| Repetitions | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 10 ± 0.88 | 6.58 ± 0.51 |
| Post-intervention | 8.3 ± 1.1 | 7.2 ± 0.84 |
Measured using a 30 yard sprint
| seconds | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 4.9 ± 0.13 | 4.99 ± 0.11 |
| Post-intervention | 4.73 ± 1 | 4.8 ± 0.12 |
This outcome is measured via maximum voluntary contraction from an isometric mid-thigh pull.
| Newton-meter (N·m) | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 168 ± 15.3 | 171 ± 9.4 |
| Post-intervention | 172 ± 12.8 | 164 ± 10.2 |
Measured via BodPod to assess the amount of fat-free mass each participant has (kg)
| kg | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 46.7 ± 2.3 | 46.1 ± 1.2 |
| Post-intervention | 47.5 ± 2.4 | 46.9 ± 1.8 |
Measured via BodPod to assess the amount of fat mass each participant has (kg)
| kg | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 11.7 ± 2.5 | 12.9 ± 1.6 |
| Post-intervention | 11 ± 2.2 | 11.8 ± 1.2 |
Measured via Fitbit devices. Sleep efficiency is measured based on how long and individual is asleep over the time spent in bed during the night.
| percent | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 92.9 ± 0.65 | 94.1 ± 0.74 |
| Post-intervention | 92.1 ± 2.3 | 94.2 ± 0.45 |
Measured via Fitbit devices. Sleep duration is measured based on how long the individual is asleep.
| hours | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 7.14 ± 0.37 | 7.33 ± 0.23 |
| Post-intervention | 7.31 ± 0.25 | 7.49 ± 0.73 |
Measured via blood sample to assess levels of fatty acid oxidation as well as inflammation
| pg/mL | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 8333719 ± 1716899 | 7339317 ± 1039637 |
| Post-intervention | 7930054 ± 1599950 | 7482251 ± 1168166 |
Measured via blood sample
| pg/mL | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 39.8 ± 14.6 | 48.7 ± 8.0 |
| Post-intervention | 51.2 ± 15.7 | 39.8 ± 9.37 |
Measured via blood sample to assess muscle hypertrophy
| pg/mL | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 103 ± 18.2 | 95.7 ± 11.8 |
| Post-intervention | 84.5 ± 15.8 | 77.0 ± 7.91 |
Measured via Pittsburgh Sleep Quality Index questionnaire. The questionnaire consists of a combination of Likerttype and open-ended questions. Each component is scored from 0 to 3, with higher scores indicating greater sleep disturbance or poorer sleep quality. Component scores are summed to yield a global PSQI score ranging from 0 to 21. A global PSQI score \>5 is commonly used to indicate poor sleep quality, whereas scores ≤5 indicate relatively good sleep quality. Each component is scored from 0 to 3, with higher scores indicating greater sleep disturbance or poorer sleep quality. Component scores are summed to yield a global PSQI score ranging from 0 to 21.
| Scores on a scale | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 4.5 ± 0.54 | 6.67 ± 0.86 |
| Post-intervention | 2.3 ± 0.58 | 5.42 ± 0.93 |
Measured via a 3-day food recall
| g/kg/day | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Baseline | 1.21 ± 0.19 | 1.37 ± 0.21 |
| Post-intervention | 1.52 ± 0.32 | 1.29 ± 0.12 |
Collected over Week 6 to week 10. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Whey Protein Supplement | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) |
| Carbohydrate Control | 0/12 (0%) | 0/12 (0%) | 1/12 (8.3%) |
| Event | Whey Protein Supplement | Carbohydrate Control |
|---|---|---|
| Upset stomach/nausea from carbohydrate placeboGastrointestinal disorders | 0/10 | 1/12 |
Adolescent athletes
| Age, Continuous(years) | Whey Protein Supplement | Carbohydrate Control | Total |
|---|---|---|---|
| Mean | 15.4 ± 0.40 | 15.8 ± 0.30 | 15.6 ± 0.30 |
| Race (NIH/OMB)(Participants) | Whey Protein Supplement | Carbohydrate Control | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 |
| White | 10 | 12 | 22 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Region of Enrollment(Participants) | Whey Protein Supplement | Carbohydrate Control | Total |
|---|---|---|---|
| United States | 10 | 12 | 22 |
| Body mass index(percentile) | Whey Protein Supplement | Carbohydrate Control | Total |
|---|---|---|---|
| Mean | 53.9 ± 33.6 | 52.9 ± 28.4 | 53.4 ± 30.1 |
| Sex: Female, Male(Participants) | Whey Protein Supplement | Carbohydrate Control | Total |
|---|---|---|---|
| Female | 5 | 8 | 13 |
| Male | 5 | 4 | 9 |
| Ethnicity (NIH/OMB)(Participants) | Whey Protein Supplement | Carbohydrate Control | Total |
|---|---|---|---|
| Hispanic or Latino | 0 | 0 | 0 |
| Not Hispanic or Latino | 10 | 12 | 22 |
| Unknown or Not Reported | 0 | 0 | 0 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Request for deidentified data can be made to the PI on a case-by-case basis.
This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.